13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q1 2017. See the latest, Q2 2026 →
Reported value
$415.20B
+4.1% on the quarter before
Positions
2,230
253 new · 195 sold out
Top 10
15.0%
of the value
Est. gain
+$18.89B
on stocks held all quarter
Est. return
+5.2%
on those stocks since Q4 2016
Positions as of Mar 31, 2017, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 28% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2016. Striped tiles are options.
Largest buys
Since Q4 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Comcast Corp New~$1.57BAdded · 0.8% → 0.8%+41,671,920 shares
- Hilton Worldwide Hldgs Inc~$1.06BAdded · 0.0% → 0.3%+18,049,760 shares
- Viacom Inc New~$913.9MAdded · 0.0% → 0.2%+19,603,597 shares
- Abbott Labs~$857.5MAdded · 0.2% → 0.4%+19,309,345 shares
- Ebay Inc~$785.7MAdded · 0.1% → 0.3%+23,404,909 shares
- Apple~$717.1MAdded · 1.0% → 1.4%+4,991,639 shares
- Microchip Technology~$566.9MAdded · 0.0% → 0.2%+7,683,717 shares
- Conocophillips~$458.8MAdded · 0.0% → 0.2%+9,200,014 shares
- Intl Paper Co~$420.1MAdded · 0.4% → 0.4%+8,273,552 shares
- Priceline Grp Inc~$377.5MAdded · 0.2% → 0.3%+212,108 shares
Largest sells
Since Q4 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Hilton Worldwide Hldgs Inc~$1.80BSold out · 0.5% → 0.0%−66,102,193 shares
- Mondelez Intl Inc~$852.1MCut · 0.5% → 0.3%−19,779,515 shares
- Csx Corp~$836.2MCut · 0.3% → 0.2%−17,962,653 shares
- Microsoft~$818.4MCut · 2.1% → 2.0%−12,425,951 shares
- St Jude Med Inc~$742.7MSold out · 0.2% → 0.0%−9,261,595 shares
- Mobileye N V Amstelveen~$739.2MCut · 0.1% → 0.0%−12,039,220 shares
- Alphabet~$690.9MCut · 0.8% → 0.7%−814,928 shares
- Incyte Corp~$565.2MCut · 0.5% → 0.4%−4,228,047 shares
- Medtronic Plc~$523.4MCut · 1.3% → 1.3%−6,497,585 shares
- Colgate Palmolive Co~$513.4MCut · 0.4% → 0.3%−7,014,711 shares
Holdings
As of Mar 31, 2017. Changes are in shares against Dec 31, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb CoCOM · shares +2.9% · price −6.9% | 2.0% | $8.30B | −$601.9M | ||||||||
| MicrosoftCOM · shares −9.1% · price +6.0% | 2.0% | $8.13B | +$459.1M | ||||||||
| Merck & Co IncCOM · shares −6.5% · price +7.9% | 1.8% | $7.38B | +$542.5M | ||||||||
| Unitedhealth Group IncCOM · shares −4.7% · price +2.5% | 1.5% | $6.18B | +$149.6M | ||||||||
| AppleCOM · shares +14% · price +24.0% | 1.4% | $5.79B | +$983.3M | ||||||||
| Medtronic PlcSHS · shares −8.7% · price +13.1% | 1.3% | $5.51B | +$638.0M | ||||||||
| Jpmorgan Chase & CoCOM · shares −3.8% · price +1.8% | 1.3% | $5.51B | +$97.2M | ||||||||
| Wells Fargo & Co NewCOM · shares −3.3% · price +1.0% | 1.3% | $5.41B | +$53.5M | ||||||||
| Allergan PlcSHS · shares −5.0% · price +13.8% | 1.2% | $5.15B | +$623.2M | ||||||||
| Eli LillyCOM · shares −0.3% · price +14.4% | 1.1% | $4.77B | +$598.3M | ||||||||
| Bank Amer CorpCOM · shares −2.8% · price +6.7% | 1.1% | $4.69B | +$296.0M | ||||||||
| Chubb LimitedCOM · shares −0.06% · price +3.1% | 1.1% | $4.52B | +$137.2M | ||||||||
| Chevron Corp NewCOM · shares +4.2% · price −8.8% | 1.1% | $4.52B | −$417.7M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares −8.9% · price +2.8% | 1.1% | $4.47B | +$121.9M | ||||||||
| Johnson & JohnsonCOM · shares −4.3% · price +8.1% | 1.00% | $4.15B | +$311.0M | ||||||||
| Exxon Mobil CorpCOM · shares +1.6% · price −9.1% | 0.98% | $4.09B | −$404.6M | ||||||||
| IntelCOM · shares −9.3% · price −0.6% | 0.97% | $4.02B | −$22.3M | ||||||||
| CiscoCOM · shares +9.8% · price +11.8% | 0.91% | $3.77B | +$363.6M | ||||||||
| Mckesson CorpCOM · shares +0.9% · price +5.6% | 0.81% | $3.37B | +$176.0M | ||||||||
| Pepsico IncCOM · shares +7.0% · price +6.9% | 0.79% | $3.29B | +$198.6M | ||||||||
| Comcast Corp NewCL A · shares +91% · price −45.6% | 0.79% | $3.28B | −$1.44B | ||||||||
| Marsh & Mclennan Cos IncCOM · shares −0.7% · price +9.3% | 0.77% | $3.22B | +$274.2M | ||||||||
| Cardinal Health IncCOM · shares −1.7% · price +13.3% | 0.77% | $3.22B | +$377.7M | ||||||||
| United Parcel Service IncCL B · shares +4.0% · price −6.4% | 0.76% | $3.15B | −$207.5M | ||||||||
| Philip Morris Intl IncCOM · shares +1.4% · price +23.4% | 0.73% | $3.03B | +$566.2M | ||||||||
| Total · 2,230 positions | 100% | $415.20B | +$18.89B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2016 to Q1 2017: 1,873 stocks held throughout, up $18.89B (+5.2%).
- Apple+$983.3M+24%
- Medtronic Plc+$638.0M+13%
- Allergan Plc+$623.2M+14%
- Eli Lilly+$598.3M+14%
- Philip Morris Intl Inc+$566.2M+23%
- Verizon Communications Inc−$234.8M−9%
- Exxon Mobil Corp−$404.6M−9%
- Chevron Corp New−$417.7M−9%
- Bristol Myers Squibb Co−$601.9M−7%
- Comcast Corp New−$1.44B−46%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |